The scientific community raises alarm over the opacity of Neuralink’s clinical experiment involving brain chip implants in humans.
Limited Information and Musk’s Disclosure
While Elon Musk confirmed the commencement of the trials on his Twitter page, official data remains absent from the National Institutes of Health’s online database.
Inadequate Technical Details
Public information about Neuralink’s technology is confined to a brochure lacking crucial details, leaving numerous questions regarding device safety and functionality unanswered.
Safety Concerns for Trial Volunteers
As human trials begin, ensuring the safety of volunteers becomes a paramount concern. Neuroengineer Tim Denison emphasizes the need to monitor potential consequences, including strokes, bleeding, vascular damage, infections, and implant safety.
Trial Duration and Monitoring
Neuralink’s brochure mentions a five-year observation period for study participants. The trials will assess the device’s functional capabilities, with volunteers using it to control computers and receiving feedback at least twice a week.
Lack of Independent Confirmation
Despite Neuralink’s claims, there is currently no independently verified evidence supporting the chip’s efficiency and its suitability for human use. A Wired investigation revealed concerns about the trials exceeding ethical boundaries at the California National Primate Research Center.
In summary, the scientific community awaits transparent and independently validated data on Neuralink’s human trials to address safety, efficacy, and ethical considerations associated with brain chip technology.
